Insider Stock Trading History of Powchik Peter


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Powchik Peter since year 2005. The trader's CIK number is 1377247. At the time of this reporting, Powchik Peter is the SVP Clinical Development & Reg of Regeneron Pharmaceuticals Inc . (stock ticker symbol REGN). See this page for all insider trading activities at Regeneron Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Powchik Peter since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-12-16 REGN Regeneron Pharmaceuticals Inc Option Ex 1,921 52.03 99,949
2015-08-13 REGN Regeneron Pharmaceuticals Inc Option Ex 60,361 116.85 7,053,182
2015-08-14 REGN Regeneron Pharmaceuticals Inc Sale 23,485 574.13 13,483,419
2015-01-02 REGN Regeneron Pharmaceuticals Inc Sale 10,822 414.71 4,487,948
2014-12-31 REGN Regeneron Pharmaceuticals Inc Option Ex 25,000 52.03 1,300,750
2014-12-19 REGN Regeneron Pharmaceuticals Inc Option Ex 3,264 30.63 99,976
2014-01-02 REGN Regeneron Pharmaceuticals Inc Sale 20,668 275.27 5,689,321
2013-12-31 REGN Regeneron Pharmaceuticals Inc Option Ex 48,000 30.63 1,470,240
2013-12-24 REGN Regeneron Pharmaceuticals Inc Option Ex 4,705 21.25 99,981
2013-12-18 REGN Regeneron Pharmaceuticals Inc Option Ex 295 21.25 6,268
2013-12-18 REGN Regeneron Pharmaceuticals Inc Sale 9,000 270.20 2,431,800
2013-12-20 REGN Regeneron Pharmaceuticals Inc Sale 133 271.09 36,054
2013-12-17 REGN Regeneron Pharmaceuticals Inc Sale 8 270.00 2,160
2013-12-16 REGN Regeneron Pharmaceuticals Inc Option Ex 30,625 87.26 2,672,429
2013-01-09 REGN Regeneron Pharmaceuticals Inc Option Ex 5,752 19.02 109,431
2013-01-03 REGN Regeneron Pharmaceuticals Inc Sale 13,586 181.93 2,471,741
2013-01-02 REGN Regeneron Pharmaceuticals Inc Option Ex 30,000 21.25 637,500
2012-12-18 REGN Regeneron Pharmaceuticals Inc Option Ex 38,248 34.64 1,324,795
2012-12-19 REGN Regeneron Pharmaceuticals Inc Sale 10,356 179.60 1,859,937
2012-12-20 REGN Regeneron Pharmaceuticals Inc Sale 6,623 170.78 1,131,042
2012-11-08 REGN Regeneron Pharmaceuticals Inc Sale 15,144 138.82 2,102,290
2012-09-18 REGN Regeneron Pharmaceuticals Inc Option Ex 15,000 16.80 252,000
2012-09-19 REGN Regeneron Pharmaceuticals Inc Sale 7,177 147.35 1,057,530
2012-08-01 REGN Regeneron Pharmaceuticals Inc Option Ex 14,990 18.78 281,512
2012-07-26 REGN Regeneron Pharmaceuticals Inc Sale 7,019 130.74 917,628
2012-07-25 REGN Regeneron Pharmaceuticals Inc Option Ex 15,000 16.80 252,000
2012-02-21 REGN Regeneron Pharmaceuticals Inc Option Ex 109,866 18.67 2,051,198
2012-02-22 REGN Regeneron Pharmaceuticals Inc Sale 49,254 96.45 4,750,548
2011-07-25 REGN Regeneron Pharmaceuticals Inc Option Ex 25,000 15.64 391,000
2011-07-26 REGN Regeneron Pharmaceuticals Inc Sale 10,977 54.96 603,350

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Powchik Peter (SVP Clinical Development & Reg of Regeneron Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.